How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

Healthcare stocks with a solid history of dividend growth are attractive to investors seeking reliable income. Here, we highlight three companies—Amgen, Merck, and AbbVie—that have demonstrated consistent dividend increases.

Amgen

Amgen (NASDAQ:AMGN) discovers, develops, manufactures, and delivers human therapeutics globally. The company serves various healthcare providers, including physicians, clinics, dialysis centers, hospitals, and pharmacies.

Amgen has maintained dividend payments for 14 consecutive years and raised them for 13 years. The company pays a quarterly dividend of $2.25 per share, or $9 annually, yielding 2.83%.

Over the past twelve months, Amgen generated $29.5 billion in revenue and $3.76 billion in net income.

Trending: Elon Musk and Jeff Bezos are bullish on one city that could dethrone New York. Investing in its booming real estate market has never been more accessible.

Merck

Merck & Co., Inc. (NYSE:MRK) operates as a global healthcare company through its Pharmaceutical and Animal Health segments. The Pharmaceutical segment offers products for oncology, acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment provides veterinary pharmaceuticals, vaccines, and health management solutions.

Merck has raised its dividend for 13 consecutive years and pays a quarterly dividend of $0.77 per share, or $3.08 annually, yielding 2.32%.

The stock is up more than 23% YTD, and the company has beaten EPS and revenue estimates for the last 11 quarters. Over the past twelve months, Merck generated $61.4 billion in revenue and $2.3 billion in net income.

AbbVie

AbbVie (NYSE:ABBV) discovers, develops, manufactures, and sells pharmaceuticals worldwide, focusing on key therapeutic areas such as immunology, oncology, neuroscience, and eye care.

AbbVie has raised its dividend for 11 consecutive years and pays a quarterly dividend of $1.55 per share, or $6.20 annually, yielding 3.59%.

Over the past twelve months, AbbVie generated $54.4 billion in revenue and $5.99 billion in net income.

Don’t Miss: This Jeff Bezos-backed startup will allow you to become a landlord in just 10 minutes, and you only need $100.

Are You Missing Out On Higher Yields?

The current high-interest-rate environment has created an incredible opportunity for income-seeking investors to earn massive yields, but not through dividend stocks... Certain private market real estate investments are giving retail investors the opportunity to capitalize on these high-yield opportunities and Benzinga has identified some of the most attractive options for you to consider.



For example, the Jeff Bezos-backed investment platform just launched its Private Credit Fund, which provides access to a pool of short-term loans backed by residential real estate with a target 7% to 9% net annual yield paid to investors monthly. The best part? Unlike other private credit funds, this one has a minimum investment of only $100.

Don't miss out on this opportunity to take advantage of high-yield investments while rates are high. Check out Benzinga's favorite high-yield offerings.

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

This article How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth? originally appeared on Benzinga.com